Skip to content

Achieve Life Sciences ACHV Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate

Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate at other companies

Achieve Life Sciences logo
Achieve Life SciencesACHV
0%
CorMedix logo
CorMedixCRMD
0%
LivaNova logo
LivaNovaLIVN
0%
Lesaka Technologies, Inc. logo
Lesaka Technologies, Inc.LSAK
0%
Q2 Holdings logo
Q2 HoldingsQTWO
0.2%
APO
Apogee EnterprisesAPOG
3.4%+2.6pp

Other financials

Income statement

See full
Net income-$10.2M+20.7%
EPS (diluted)-$0.19+48.6%

Balance sheet

See full
Cash & equivalents$28.1M+116%
Total debt$5.6M+332%
Total equity$10.7M+3.9%
Total assets$33.1M+21.0%

Cash flow

See full
Operating cash flow-$6.9M+37.5%
CapEx$750.0
Free cash flow-$12.4M

Valuation

See full
Market cap$585.16M+404%
Enterprise value$562.71M+439%

Returns & leverage

See full
Return on equity-496.1%-906pp
Debt / equity0.5×+0.4×
Current ratio2.6×-0.9×

Where this comes from

Reported directly by Achieve Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate.

The official record: Achieve Life Sciences’s 10-K, filed March 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Achieve Life Sciences's effective income tax rate reconciliation change in enacted tax rate.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Achieve Life Sciences's effective income tax rate reconciliation change in enacted tax rate?
Achieve Life Sciences (ACHV) reported effective income tax rate reconciliation change in enacted tax rate of 0% in Q4 2025.
What does effective income tax rate reconciliation change in enacted tax rate mean?
This metric represents the impact of changes in enacted tax laws or rates on the company's effective tax rate reconciliation. It highlights how legislative shifts in tax jurisdictions influence the company's overall tax burden. Investors use this to assess exposure to regulatory tax volatility.